glycine has been researched along with Hodgkin Disease in 6 studies
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In ixazomib-treated TCL and HL cells, transient inhibition followed by full recovery of proteasomal activity observed was accompanied by induction of proteasomal gene expression with NFE2L2 (also termed NRF2) as a prominent upstream regulator." | 5.56 | Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma. ( Beheshti, A; David, KA; Evens, AM; McDonald, JT; Passero, FC; Ravi, D, 2020) |
| "This systematic review and meta-analysis rigorously examines the relationship between glyphosate exposure and risk of lymphohematopoietic cancer (LHC) including NHL, Hodgkin lymphoma (HL), multiple myeloma (MM), and leukemia." | 4.93 | Systematic review and meta-analysis of glyphosate exposure and risk of lymphohematopoietic cancers. ( Chang, ET; Delzell, E, 2016) |
| "In ixazomib-treated TCL and HL cells, transient inhibition followed by full recovery of proteasomal activity observed was accompanied by induction of proteasomal gene expression with NFE2L2 (also termed NRF2) as a prominent upstream regulator." | 1.56 | Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma. ( Beheshti, A; David, KA; Evens, AM; McDonald, JT; Passero, FC; Ravi, D, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Passero, FC | 1 |
| Ravi, D | 2 |
| McDonald, JT | 1 |
| Beheshti, A | 2 |
| David, KA | 1 |
| Evens, AM | 2 |
| Abermil, N | 1 |
| Passero, F | 1 |
| Sharma, J | 1 |
| Coyle, M | 1 |
| Kritharis, A | 1 |
| Kandela, I | 1 |
| Hlatky, L | 1 |
| Sitkovsky, MV | 1 |
| Mazar, A | 1 |
| Gartenhaus, RB | 1 |
| Chang, ET | 1 |
| Delzell, E | 1 |
| BERLIN, NI | 1 |
| SVIRCEVIC, A | 1 |
| TEPAVCEVIC, P | 1 |
| KOVAC, T | 1 |
| Kongsvik, JR | 1 |
| Messineo, L | 1 |
2 reviews available for glycine and Hodgkin Disease
| Article | Year |
|---|---|
Systematic review and meta-analysis of glyphosate exposure and risk of lymphohematopoietic cancers.
Topics: Glycine; Glyphosate; Herbicides; Hodgkin Disease; Humans; Leukemia; Multiple Myeloma; Neoplasms; Ris | 2016 |
DETERMINATION OF RED BLOOD CELL LIFE SPAN.
Topics: Anemia; Carbon Isotopes; Chromium Isotopes; Erythrocytes; Glycine; Hemoglobins; Hemoglobins, Abnorma | 1964 |
4 other studies available for glycine and Hodgkin Disease
| Article | Year |
|---|---|
Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boron Compounds; Cell Line, Tumor; Down-R | 2020 |
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Boron Compounds; Cell Proliferation; Check | 2016 |
[EXPERIENCES IN THE USE OF AVAFORTAN, A SPASMO-ANALGESIC AGENT].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Biliary Dyskinesia; Cholecystitis; C | 1965 |
The isolation and characterization of deoxyribonucleoproteins from human spleen.
Topics: Acetates; Amino Acids; Animals; Antigens; Buffers; Cellulose; Chromatography, Gel; Dextrans; DNA; El | 1970 |